Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. uri icon

Overview

authors

publication date

  • March 1, 2015

Identity

PubMed Central ID

  • PMC4349252

Scopus Document Identifier

  • 84924340539

Digital Object Identifier (DOI)

  • 10.1038/cr.2015.28

PubMed ID

  • 25732764

Additional Document Info

volume

  • 25

issue

  • 3